Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components

Nature Medicine volume 18, pages 791–798 (2012)Cite this article

Subjects

Abstract

Age-related macular degeneration (AMD) is the leading cause of central vision loss worldwide. Drusen accumulation is the major pathological hallmark common to both dry and wet AMD. Although activation of the immune system has been implicated in disease progression, the pathways involved are unclear. Here we show that drusen isolated from donor AMD eyes activates the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome, causing secretion of interleukin-1β (IL-1β) and IL-18. Drusen component C1Q also activates the NLRP3 inflammasome. Moreover, the oxidative-stress–related protein-modification carboxyethylpyrrole (CEP), a biomarker of AMD, primes the inflammasome. We found cleaved caspase-1 and NLRP3 in activated macrophages in the retinas of mice immunized with CEP-adducted mouse serum albumin, modeling a dry-AMD–like pathology. We show that laser-induced choroidal neovascularization (CNV), a mouse model of wet AMD, is exacerbated in Nlrp3−/− but not Il1r1−/− mice, directly implicating IL-18 in the regulation of CNV development. These findings indicate a protective role for NLRP3 and IL-18 in the progression of AMD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Drusen activates the NLRP3 inflammasome.
Figure 2: CEP (CEP-HSA), a component of drusen, can prime the NLRP3 inflammasome.
Figure 3: Complement factor C1Q, a component of drusen, activates the NLRP3 inflammasome.
Figure 4: Cleaved caspase-1 p10 colocalizes with activated macrophages in CEP-MSA–immunized mice.
Figure 5: NLRP3 is protective against laser-induced CNV lesion formation in an IL-1β–independent manner.
Figure 6: NLRP3 confers its protection against CNV lesion formation through its role in IL-18 production, which in turn regulates VEGF concentrations.

Similar content being viewed by others

References

  1. Swaroop, A., Chew, E.Y., Rickman, C.B. & Abecasis, G.R. Unravelling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu. Rev. Genomics Hum. Genet. 10, 19–43 (2009).

    Article  CAS  Google Scholar 

  2. Resnikoff, S. et al. Global data on visual impairment in the year 2002. Bull. World Health Organ. 82, 844–851 (2004).

    Google Scholar 

  3. Bressler, S.B., Maguire, M.G., Bressler, N.M. & Fine, S.L. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch. Ophthalmol. 108, 1442–1447 (1990).

    Article  CAS  Google Scholar 

  4. Sarks, S.H., van Driel, D., Maxwell, L. & Killingsworth, M. Softening of drusen and subretinal neovascularization. Trans. Ophthalmol. Soc. U.K. 100, 414–422 (1980).

    CAS  Google Scholar 

  5. Vinding, T. Occurrence of drusen, pigmentary changes, and exudative changes in the macula with reference to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. (Copenh.) 68, 410–414 (1990).

    Article  CAS  Google Scholar 

  6. Holz, F.G., Bellman, C., Staudt, S., Schutt, F. & Volcker, H.E. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 42, 1051–1056 (2001).

    CAS  Google Scholar 

  7. Seddon, J.M., George, S. & Rosner, B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch. Ophthalmol. 124, 995–1001 (2006).

    Article  CAS  Google Scholar 

  8. Edwards, A.O. & Malek, G. Molecular genetics of AMD and current animal models. Angiogenesis 10, 119–132 (2007).

    Article  CAS  Google Scholar 

  9. Canter, J.A. et al. Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS ONE 3, e2091 (2008).

    Article  Google Scholar 

  10. Chen, Y., Bedell, M. & Zhang, K. Age-related macular degeneration: genetic and environmental factors of disease. Mol. Interv. 10, 271–281 (2010).

    Article  CAS  Google Scholar 

  11. Leveziel, N. et al. Genetic factors associated with age-related macular degeneration. Ophthalmologica 226, 87–102 (2011).

    Article  CAS  Google Scholar 

  12. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228–232 (2006).

    Article  CAS  Google Scholar 

  13. Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).

    Article  CAS  Google Scholar 

  14. Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9, 857–865 (2008).

    Article  CAS  Google Scholar 

  15. Zhou, R., Yazdi, A.S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).

    Article  CAS  Google Scholar 

  16. Gao, H. & Hollyfield, J.G. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 33, 1–17 (1992).

    CAS  Google Scholar 

  17. Iyer, S.S. et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA 106, 20388–20393 (2009).

    Article  CAS  Google Scholar 

  18. Hollyfield, J.G. et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 14, 194–198 (2008).

    Article  CAS  Google Scholar 

  19. Gu, X. et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem. 278, 42027–42035 (2003).

    Article  CAS  Google Scholar 

  20. Sakurai, E. et al. Macrophage depletion inhibits experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3578–3585 (2003).

    Article  Google Scholar 

  21. Campbell, M. et al. Systemic low molecular weight drug delivery to pre-selected neuronal regions. EMBO Mol. Med. 3, 235–245 (2011).

    Article  CAS  Google Scholar 

  22. Ma, W., Zhao, L., Fontainhas, A.M., Fariss, R.N. & Wong, W.T. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS ONE 4, e7945 (2009).

    Article  Google Scholar 

  23. Anderson, D.H. et al. Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res. 78, 243–256 (2004).

    Article  CAS  Google Scholar 

  24. Luibl, V. et al. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J. Clin. Invest. 116, 378–385 (2006).

    Article  CAS  Google Scholar 

  25. Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).

    Article  CAS  Google Scholar 

  26. Masters, S.L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat. Immunol. 11, 897–904 (2010).

    Article  CAS  Google Scholar 

  27. Lin, H. et al. Mitochondrial DNA damage and repair in RPE associated with aging and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 52, 3521–3529 (2011).

    Article  CAS  Google Scholar 

  28. Wang, A.L. et al. Autophagy, exosomes and drusen formation in age-related macular degeneration. Autophagy 5, 563–564 (2009).

    Article  CAS  Google Scholar 

  29. Zarbin, M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 122, 598–614 (2004).

    Article  Google Scholar 

  30. West, X.Z. et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972–976 (2010).

    Article  CAS  Google Scholar 

  31. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).

    Article  CAS  Google Scholar 

  32. Hageman, G.S. & Mullins, R.F. Molecular composition of drusen as related to substructural phenotype. Mol. Vis. 5, 28–(1999).

  33. Nauta, A.J. et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 32, 1726–1736 (2002).

    Article  CAS  Google Scholar 

  34. Blanquet-Grossard, F., Thielens, N.M., Vendrely, C., Jamin, M. & Arlaud, G.J. Complement protein C1q recognizes a conformationally modified form of the prion protein. Biochemistry 44, 4349–4356 (2005).

    Article  CAS  Google Scholar 

  35. Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847–856 (2008).

    Article  CAS  Google Scholar 

  36. Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136–140 (2010).

    Article  CAS  Google Scholar 

  37. Luo, X., Weber, G.A., Zheng, J., Gendelman, H.E. & Ikezu, T. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. J. Neuroimmunol. 135, 62–71 (2003).

    Article  CAS  Google Scholar 

  38. Ten, V.S. et al. Complement component c1q mediates mitochondria-driven oxidative stress in neonatal hypoxic-ischemic brain injury. J. Neurosci. 30, 2077–2087 (2010).

    Article  CAS  Google Scholar 

  39. McDonald, B. et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330, 362–366 (2010).

    Article  CAS  Google Scholar 

  40. CATT Research Group. et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 364, 1897–1908 (2011).

  41. Crabb, J.W. et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 99, 14682–14687 (2002).

    Article  CAS  Google Scholar 

  42. Ishii, T., Haga, S., Yagishita, S. & Tateishi, J. The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease. Appl. Pathol. 2, 370–379 (1984).

    CAS  Google Scholar 

  43. Xu, H., Chen, M. & Forrester, J.V. Para-inflammation in the aging retina. Prog. Retin. Eye Res. 28, 348–368 (2009).

    Article  Google Scholar 

  44. Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428–435 (2008).

    Article  CAS  Google Scholar 

  45. Arias, L. et al. Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy. Retina 30, 1601–1608 (2010).

    Article  Google Scholar 

  46. Giganti, M. et al. Adverse events after intravitreal infliximab (Remicade). Retina 30, 71–80 (2010).

    Article  Google Scholar 

  47. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367–378 (2010).

    Article  CAS  Google Scholar 

  48. Allen, I.C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045–1056 (2010).

    Article  CAS  Google Scholar 

  49. Qiao, H. et al. Abnormal retinal vascular development in IL-18 knockout mice. Lab. Invest. 84, 973–980 (2004).

    Article  CAS  Google Scholar 

  50. Qiao, H. et al. Interleukin-18 regulates pathological intraocular neovascularization. J. Leukoc. Biol. 81, 1012–1021 (2007).

    Article  CAS  Google Scholar 

  51. Mallat, Z. et al. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ. Res. 91, 441–448 (2002).

    Article  CAS  Google Scholar 

  52. Coughlin, C.M. et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441–1452 (1998).

    Article  CAS  Google Scholar 

  53. Jiang, H.R. et al. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest. Ophthalmol. Vis. Sci. 42, 177–182 (2001).

    CAS  Google Scholar 

  54. Gu, X. et al. Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and peptide adduction chemistry. J. Org. Chem. 68, 3749–3761 (2003).

    Article  CAS  Google Scholar 

  55. Percopo, C.M., Hooks, J.J., Shinohara, T., Caspi, R. & Detrick, B. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J. Immunol. 145, 4101–4107 (1990).

    CAS  Google Scholar 

  56. Marmor, M.F. et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc. Ophthalmol. 1, 69–77 (2009).

    Article  Google Scholar 

Download references

Acknowledgements

The Ocular Genetics Unit at Trinity College Dublin is supported by the American Health Assistance Foundation (AHAF), Science Foundation Ireland (SFI), The Health Research Board of Ireland (HRB), Irish Research Council for Science Engineering and Technology (IRCSET), Enterprise Ireland (EI), Telemedicine and Advanced Technology Research Center (TATRC) and Fighting Blindness Ireland (FB-Ireland). S.L.D. and L.A.J.O. are supported by the SFI Immunology Research Centre (IRC) and the SFI Strategic Research Cluster (07/SRC/B1144). Support for the laboratory of J.G.H. was provided by the US National Institutes of Health through grant EY014240, the Macular Vision Research Foundation, Research to Prevent Blindness and the Llura and Gordon Gund Foundation. Support for the laboratory of R.G.S. was provided by the US National Institutes of Health through grants GM021249 and EY016813. Support for the laboratory of E.C.L. was from SFI grant number 08/RFP/MBT1363 and SFI Strategic Research Cluster 07/SRC/B1144. We would like to thank C. Woods, C. Murray, D. Flynn and R. Robertson for animal husbandry. The authors would also like to thank the Research Foundation at the Royal Victoria Eye and Ear Hospital for assistance in the acquisition of the Iridex laser system. We thank E. Latz (University of Bonn) for the provision of BMDMs expressing YFP-labeled ASC. We would like to acknowledge the expertise of K. Shadrach in isolating drusen from AMD donor eyes.

Author information

Author notes

  1. Sarah L Doyle and Matthew Campbell: These authors contributed equally to this work.

Authors and Affiliations

  1. School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland

    Sarah L Doyle, Andres Mori, Ed C Lavelle & Luke A J O'Neill

  2. Ocular Genetics Unit, Smurfit Institute of Genetics, Lincoln Place Gate, Trinity College Dublin, Dublin 2, Ireland

    Matthew Campbell, Ema Ozaki, Paul F Kenna, Gwyneth Jane Farrar, Anna-Sophia Kiang, Marian M Humphries & Peter Humphries

  3. Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, USA

    Robert G Salomon

  4. The Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin 2, Ireland.,

    Paul F Kenna

  5. Department of Ophthalmology, Cole Eye Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA

    Joe G Hollyfield

Authors
  1. Sarah L Doyle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ema Ozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert G Salomon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andres Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paul F Kenna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gwyneth Jane Farrar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anna-Sophia Kiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marian M Humphries
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ed C Lavelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Luke A J O'Neill
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Joe G Hollyfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Peter Humphries
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.L.D. and M.C. conceived of, designed and performed experiments and wrote the paper. E.O. performed experiments. R.G.S. prepared the CEP-HSA. A.M. genotyped all animals reported in the paper and isolated cells. P.F.K. performed ERG analyses. G.J.F., A.-S.K. and M.M.H. contributed to analysis of experiments and data. E.C.L. and L.A.J.O. conceived of experiments and analyzed data. J.G.H. isolated drusen and wrote the paper. P.H. conceived of and designed experiments and wrote the paper.

Corresponding author

Correspondence to Matthew Campbell.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Methods and Supplementary Figures 1–14 (PDF 1241 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doyle, S., Campbell, M., Ozaki, E. et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 18, 791–798 (2012). https://doi.org/10.1038/nm.2717

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2717

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing